Anatomic basis of leptin action in the hypothalamus

Frontiers of Hormone Research

Volumn 26, Issue , 1999, Pages 21-41

  Elmquist, Joel K ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CELL SURFACE RECEPTOR; LEPTIN; LEPTIN RECEPTOR;

ANIMAL; DRUG EFFECT; HUMAN; HYPOTHALAMUS; REPRODUCTION; REVIEW; THYROID GLAND;

ANIMALS; CARRIER PROTEINS; HUMANS; HYPOTHALAMUS; LEPTIN; RECEPTORS, CELL SURFACE; REPRODUCTION; THYROID GLAND;

EID: 0033651790     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000061020     Document Type: Article

References (100)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
2. Spiegelman BM, Flier JS: Adipogenesis and obesity: Rounding out the big picture. Cell 1996;87:377-389.
3. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995;269:543-546.
4. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
5. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T, Collins F: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995;269:540-543.
6. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS: Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
7. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS: Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1995;1:1311-1314.
8. Schwartz MW, Dallman MF, Woods SC: Hypothalamic response to starvation: Implications for the study of wasting disorders. Am J Physiol 1995;269:R949-R957.
9. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, et al: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995;377:530-532.
10. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS: Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997;138:3859-3863.
11. Huang Q, Rivest R, Richard D: Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 1998;139:1524-1532.
12. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101-1106.
13. Sawchenko PE, Brown ER, Chan RK, Ericsson A, Li HY, Roland BL, Kovacs KJ: The paraventricular nucleus of the hypothalamus and the functional neuroanatomy of visceromotor responses to stress. Prog Brain Res 1996;107:201-222.
14. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C: Regulation of in vivo growth hormone secretion by leptin. Endocrinology 1997;138:2203-2206.
15. Quintela M, Senaris R, Heiman ML, Casanueva FF, Dieguez C: Leptin inhibits in vitro hypothalamic somatostatin secretion and somatostatin mRNA levels. Endocrinology 1997;138:5641-5644.
16. Blake NG, Eckland DJ, Foster OJ, Lightman SL: Inhibition of hypothalamic thyrotropin-releasing hormone messenger ribonucleic acid during food deprivation. Endocrinology 1991;129:2714-2718.
17. Legradi G, Emerson CH, Ahima RS, Flier JS, Lechan RM: Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997;138:2569-2576.
18. Chehab FF, Lim ME, Lu R: Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996;12:318-320.
19. Barash IA, Cheung CC, Weigle DS, Ren H, Kabigting EB, Kuijper JL, Clifton DK, Steiner RA: Leptin is a metabolic signal to the reproductive system. Endocrinology 1996;137:3144-3147.
20. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS: Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997;99:391-395.
21. Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA: Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 1997;138:855-858.
22. Chehab FF, Mounzih K, Lu R, Lim ME: Early onset of reproductive function in normal female mice treated with leptin. Science 1997;275:88-90.
23. Mantzoros CS, Flier JS, Rogol AD: A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997;82:1066-1070.
24. Plant TM, Durrant AR: Circulating leptin does not appear to provide a signal for triggering the initiation of puberty in the male rhesus monkey (Macaca mulatta). Endocrinology 1997;138:4505-4508.
25. Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM: Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 1997;94:1023-1028.
26. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-908.
27. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et al: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263-1271.
28. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P: Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 1996;8:733-735.
29. Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Trayhurn PL: Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett 1996;387:113-116.
30. Mercer JG, Moar KM, Rayner DV, Trayhurn P, Hoggard N: Regulation of leptin receptor and NPY gene expression in hypothalamus of leptin-treated obese (ob/ob) and cold-exposed lean mice. FEBS Lett 1997;402:185-188.
31. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R, Friedman JM: Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 1997;94:7001-7005.
32. Elmquist JK, Bjørbzek C, Ahima RS, Flier JS, Saper CB: Distributions of leptin receptor isoforms in the rat brain. J Comp Neurol 1998;395:535-547.
33. Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492.
34. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632-635.
35. Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP: Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996;84:491-495.
36. White DW, Wang DW, Chua SC Jr, Morgenstern JP, Leibel RL, Baumann H, Tartaglia LA: Constitutive and impaired signaling of leptin receptors containing the Gin → Pro extracellular domain fatty mutation. Proc Natl Acad Sci USA 1997;94:10657-10662.
37. Savioz A, Charnay Y, Huguenin C, Graviou C, Greggio B, Bouras C: Expression of leptin receptor mRNA (long splice form variant) in the human cerebellum. NeuroReport 1997;8:3123-3126.
38. Mercer JG, Moar KM, Hoggard N: Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. Endocrinology 1998;139:29-34.
39. Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV: Localization of leptin receptor in the human brain. Neuroendocrinology 1997;66:145-150.
40. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci 1998;18:559-572.
41. Smedh U, Hakansson ML, Meister B, Uvnas-Moberg K: Leptin injected into the fourth ventricle inhibits gastric emptying (in process citation). NeuroReport 1998;9:297-301.
42. Bi S, Gavrilova O, Gong DW, Mason MM, Reitman M: Identification of a placental enhancer for the human leptin gene. J Biol Chem 1997;272:30583-30588.
43. Broadwell RD, Brightman MW: Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol 1976;166:257-283.
44. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996;17:305-311.
45. Erickson JC, Hollopeter G, Palmiter RD: Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y Science 1996;274:1704-1707.
46. Erickson JC, Clegg KE, Palmiter RD: Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y (see comments). Nature 1996;381:415-421.
47. Erickson JC, Ahima RS, Hollopeter G, Flier JS, Palmiter RD: Endocrine function of neuropeptie Y knockout mice. Regul Pept 1997;70:199-202.
48. Thornton JE, Cheung CC, Clifton DK, Steiner RA: Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-5066.
49. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG: Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123.
50. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV: Hypothalamic proopiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1998;47:294-297.
51. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-168.
52. Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL: Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 1997;11:593-602.
53. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997;278:135-138.
54. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects. Nature 1997;390:349.
55. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
56. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-1308.
57. Vaisse C, Halaas JL, Horvath CM, Darnell JE Jr, Stoffel M, Friedman JM: Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996;14:95-97.
58. Hoffman GE, Smith MS, Verbalis JG: c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 1993;14:173-213.
59. Woods AJ, Stock MJ: Leptin activation in hypothalamus (letter). Nature 1996;381:745.
60. Van Dijk G, Thiele TE, Donahey JC, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ: Central infusions of leptin and GLP-l-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 1996;271:R1096-R1100.
61. Elmquist JK, Ahima RS, Maratos-Flier E, Flier JS, Saper CB: Leptin activates neurons in ventrobasal hypothalamus and brainstem. Endocrinology 1997;138:839-842.
62. Hetherington AW, Ranson SW: Hypothalamic lesions and adiposity in the rat. Anat Rec 1940;78:149.
63. Gold RM: Hypothalamic obesity: The myth of the ventromedial nucleus. Science 1973;182:488-490.
64. Bernardis LL, Bellinger LL: The dorsomedial hypothalamic nucleus revisited: 1986 update. Brain Res 1987;44:321-381.
65. Baker RA, Herkenham M: Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: Neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 1995;358:518-530.
66. Leibowitz SF: Brain neuropeptide Y: An integrator of endocrine, metabolic and behavioral processes. Brain Res Bull 1991;27:333-337.
67. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford ML: Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997;390:521-525.
68. Glaum SR, Hara M, Bindokas VP, Lee CC, Polonsky KS, Bell GI, Miller RJ: Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. Mol Pharmacol 1996;50:230-235.
69. Chan RK, Brown ER, Ericsson A, Kovacs KJ, Sawchenko PE: A comparison of two immediateearly genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circitry. J Neurosci 1993;13:5126-5138.
70. Sawchenko PE, Swanson LW, Rivier J, Vale WW: The distribution of growth-hormone-releasing factor (GRF) immunoreactivity in the central nervous system of the rat: An immunohistochemical study using antisera directed against rat hypothalamic GRF. J Comp Neurol 1985;237:100-115.
71. Fulwiler CE, Saper CB: Cholecystokinin-immunoreactive innervation of the ventromedial hypothalamus in the rat: Possible substrate for autonomic regulation of feeding. Neurosci Lett 1985;53:289-296.
72. Weller A, Smith GP, Gibbs J: Endogenous cholecystokinin reduces feeding in young rats. Science 1990;247:1589-1591.
73. Barrachina MD, Martinez V, Wang L, Wei JY, Tach Y: Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 1997;94:10455-10460.
74. Bjørbzek C, Elmquist JK, Frazier JD, Shoelson SE, Flier JS: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-625.
75. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A: A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387:921-924.
76. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Mitcalf D, Nicola NA, Hilton DJ: A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-921.
77. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T: Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387:924-929.
78. Swanson LW, Sawchenko PE: Hypothalamic integration: Organization of the paraventricular and supraoptic nuclei. Annu Rev Neurosci 1983;6:269-324.
79. Saper CB: Central autonomic system; in Paxinos G (ed): The Rat Nervous System. San Diego, Academic Press, 1995, pp 107-135.
80. Rogers RC, Hermann GE: Dorsal medullary oxytocin, vasopressin, oxytocin antagonist, and TRH effects on gastric acid secretion and heart rate. Peptides 1985;6:1143-1148.
81. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270-278.
82. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation (letter). Nature 1996;380:677.
83. Elmquist JK, Ahima RS, Elias CF, Flier JS, Saper CB: Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. Proc Natl Acad USA 1998;95:741-746.
84. Yoshimatsu H, Niijima A, Oomura Y, Yamabe K, Katafuchi T: Effects of hypothalamic lesion on pancreatic autonomic nerve activity in the rat. Brain Res 1984;303:147-152.
85. Frohman LA, Bernardis LL: Effect of hypothalamic stimulation on plasma glucose, insulin, and glucagon levels. Am J Physiol 1971;221:1596-1603.
86. ter Horst GJ, Luiten PG: The projections of the dorsomedial hypothalamic nucleus in the rat. Brain Res Bull 1986;16:231-248.
87. Thompson RH, Canteras NS, Swanson LW: Organization of projections from the dorsomedial nucleus of the hypothalamus: A PHA-L study in the rat. J Comp Neurol 1996;376:143-173.
88. ter Horst GJ, Hautvast RW, De Jongste MJ, Korf J: Neuroanatomy of cardiac activity-regulating circuitry: A transneuronal retrograde viral labelling study in the rat. Eur J Neurosci 1996;8:2029-2041.
89. Watts AG, Swanson LW: Efferent projections of the suprachiasmatic nucleus. II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat. J Comp Neurol 1987;258:230-252.
90. Watts AG, Swanson LW, Sanchez-Watts G: Efferent projections of the suprachiasmatic nucleus. I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat. J Comp Neurol 1987;258:204-229.
91. Watts AG: The efferent projections of the suprachiasmatic nucleus: Anatomical insights into the control of circadian rhythms; in Klein D, Moore RY, Reppert SM (eds): Suprachiasmatic Nucleus: The Mind's Clock. Oxford, Oxford University Press, 1991, pp 75-104.
92. Krieger DT: Food and water restriction shifts corticosterone, temperature, activity and brain amine periodicity. Endocrinology 1974;95:1195-1201.
93. Krieger DT, Hauser H, Krey LC: Suprachiasmatic nuclear lesions do not abolish food-shifted circadian adrenal and temperature rhythmicity. Science 1977;197:398-399.
94. Moberg GP, Bellinger LL, Mendel VE: Effect of meal feeding on daily rhythms of plasma corticosterone and growth hormone in the rat. Neuroendocrinology 1975;19:160-169.
95. Krieger DT: Ventromedial hypothalamic lesions abolish food-shifted circadian adrenal and temperature rhythmicity. Endocrinology 1980;106:649-654.
96. Bellinger LL, Bernardis LL, Mendel VE: Effect of ventromedial and dorsomedial hypothalamic lesions on circadian corticosterone rhythms. Neuroendocrinology 1976;22:216-225.
97. Choi S, Horsley C, Aguila S, Dallman MF: The hypothalamic ventromedial nuclei couple activity in the hypothalamo-pituitary-adrenal axis to the morning fed or fasted state. J Neurosci 1996;16:8170-8180.
98. Suemaru S, Darlington DN, Akana SF, Cascio CS, Dallman MF: Ventromedial hypothalamic lesions inhibit corticosteroid feedback reglation of basal ACTH during the trough of the circadian rhythm. Neuroendocrinology 1995;61:453-463.
99. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW: Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997;3:575-579.
100. Ahima RS, Prabakaran D, Flier JS: Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding: Implications for energy homeostasis and neuroendocrine function. J Clin Invest 1998;101:1020-1027.